Transcriptional activation of the adenoviral genome is mediated by capsid protein VI

PLoS Pathogens

Volumn 8, Issue 2, 2012, Pages

  Schreiner, Sabrina ^a   Martinez, Ruben ^b   Groitl, Peter ^a   Rayne, Fabienne ^b   Vaillant, Remi ^b   Wimmer, Peter ^a   Bossis, Guillaume ^c   Sternsdorf, Thomas ^d   Marcinowski, Lisa ^e   Ruzsics, Zsolt ^e   Dobner, Thomas ^a   Wodrich, Harald ^b  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b University Victor Segalen   (France)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^d Research Institute   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DAXX PROTEIN; PROTEIN VP6; VIRUS DNA; CAPSID PROTEIN; DAXX PROTEIN, HUMAN; MUTANT PROTEIN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PROMOTER REGION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENE; VIRUS REPLICATION; CELL CULTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN MOTIF; REPRODUCTIVE FITNESS; TRANSCRIPTION INITIATION; VIRUS GENOME;

DNA VIRUSES; HUMAN ADENOVIRUS; MIRIDAE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRIDAE; AMINO ACID MOTIFS; CAPSID PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; GENETIC FITNESS; GENOME, VIRAL; HUMANS; MUTANT PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84860898618     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002549     Document Type: Article

References (75)

1. Berk AJ, (2005) Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24: 7673-7685.
2. Weitzman MD, Lilley CE, Chaurushiya MS, (2010) Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol 64: 61-81.
3. Everett RD, Chelbi-Alix MK, (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89: 819-830.
4. Geoffroy MC, Chelbi-Alix MK, (2011) Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res 31: 145-158.
5. Salomoni P, Khelifi AF, (2006) Daxx: death or survival protein? Trends Cell Biol 16: 97-104.
6. Yang X, Khosravi-Far R, Chang HY, Baltimore D, (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067-1076.
7. Gostissa M, Morelli M, Mantovani F, Guida E, Piazza S, et al. (2004) The transcriptional repressor hDaxx potentiates p53-dependent apoptosis. J Biol Chem 279: 48013-48023.
8. Hollenbach AD, Sublett JE, McPherson CJ, Grosveld G, (1999) The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J 18: 3702-3711.
9. Kim HJ, Lim SC, Kim SH, Kim TY, (2003) Induction of apoptosis and expression of cell cycle regulatory proteins in response to a phytosphingosine derivative in HaCaT human keratinocyte cells. Mol Cells 16: 331-337.
10. Park J, Lee JH, La M, Jang MJ, Chae GW, et al. (2007) Inhibition of NF-kappaB acetylation and its transcriptional activity by Daxx. J Mol Biol 368: 388-397.
11. Li R, Pei H, Watson DK, Papas TS, (2000) EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19: 745-753.
12. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G, (2002) Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci 115: 3319-3330.
13. Chang CC, Lin DY, Fang HI, Chen RH, Shih HM, (2005) Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. J Biol Chem 280: 10164-10173.
14. Wethkamp N, Klempnauer KH, (2009) Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta. J Biol Chem 284: 28783-28794.
15. Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, et al. (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10: 196-207.
16. Day PM, Roden RB, Lowy DR, Schiller JT, (1998) The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol 72: 142-150.
17. Maul GG, Ishov AM, Everett RD, (1996) Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217: 67-75.
18. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J, (1996) The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229: 155-158.
19. Tavalai N, Papior P, Rechter S, Stamminger T, (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82: 126-137.
20. Lukashchuk V, Everett RD, (2010) Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol 84: 4026-4040.
21. Schreiner S, Wimmer P, Sirma H, Everett RD, Blanchette P, et al. (2010) Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 84: 7029-7038.
22. McFarlane S, Preston CM, (2011) Human cytomegalovirus immediate early gene expression in the osteosarcoma line U2OS is repressed by the cell protein ATRX. Virus Res 157: 47-53.
23. Hwang J, Kalejta RF, (2007) Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367: 334-338.
24. Everett RD, (2001) DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20: 7266-7273.
25. Geoffroy MC, Chelbi-Alix MK, (2011) Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res 31: 145-158.
26. Florin L, Schafer F, Sotlar K, Streeck RE, Sapp M, (2002) Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 295: 97-107.
27. Endter C, Dobner T, (2004) Cell transformation by human adenoviruses. Curr Top Microbiol Immunol 273: 163-214.
28. Carvalho T, Seeler JS, Ohman K, Jordan P, Pettersson U, et al. (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol 131: 45-56.
29. Puvion-Dutilleul F, Venturini L, Guillemin MC, de The H, Puvion E, (1995) Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection. Exp Cell Res 221: 448-461.
30. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR, (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79: 1992-2000.
31. Moyer CL, Wiethoff CM, Maier O, Smith JG, Nemerow GR, (2011) Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol 85: 2631-2641.
32. Meier O, Greber UF, (2003) Adenovirus endocytosis. J Gene Med 5: 451-462.
33. Greber UF, (1998) Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor. Rev Med Virol 8: 213-222.
34. Leopold PL, Crystal RG, (2007) Intracellular trafficking of adenovirus: many means to many ends. Adv Drug Deliv Rev 59: 810-821.
35. Smith JG, Wiethoff CM, Stewart PL, Nemerow GR, (2010) Adenovirus. Curr Top Microbiol Immunol 343: 195-224.
36. Wodrich H, Henaff D, Jammart B, Segura-Morales C, Seelmeir S, et al. (2010) A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog 6: e1000808.
37. Nevins JR, (1981) Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 26: 213-220.
38. Wodrich H, Guan T, Cingolani G, Von Seggern D, Nemerow G, et al. (2003) Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. Embo J 22: 6245-6255.
39. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
40. Raychaudhuri P, Rooney R, Nevins JR, (1987) Identification of an E1A-inducible cellular factor that interacts with regulatory sequences within the adenovirus E4 promoter. Embo J 6: 4073-4081.
41. Lee KA, Hai TY, SivaRaman L, Thimmappaya B, Hurst HC, et al. (1987) A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters. Proc Natl Acad Sci U S A 84: 8355-8359.
42. Ishov AM, Vladimirova OV, Maul GG, (2002) Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J Virol 76: 7705-7712.
43. Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, et al. (2008) Dynamics of component exchange at PML nuclear bodies. J Cell Sci 121: 2731-2743.
44. Saffert RT, Kalejta RF, (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80: 3863-3871.
45. Preston CM, Nicholl MJ, (2006) Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87: 1113-1121.
46. Xu ZX, Zhao RX, Ding T, Tran TT, Zhang W, et al. (2004) Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression. J Biol Chem 279: 1838-1844.
47. Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H, (2004) PML nuclear bodies and apoptosis. Oncogene 23: 2819-2824.
48. Cuchet-Lourenco D, Boutell C, Lukashchuk V, Grant K, Sykes A, et al. (2011) SUMO Pathway Dependent Recruitment of Cellular Repressors to Herpes Simplex Virus Type 1 Genomes. PLoS Pathog 7: e1002123.
49. Huang L, Xu GL, Zhang JQ, Tian L, Xue JL, et al. (2008) Daxx interacts with HIV-1 integrase and inhibits lentiviral gene expression. Biochem Biophys Res Commun 373: 241-245.
50. Greger JG, Katz RA, Ishov AM, Maul GG, Skalka AM, (2005) The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol 79: 4610-4618.
51. Barber GN, (2011) Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol 23: 10-20.
52. Ross PJ, Kennedy MA, Parks RJ, (2009) Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression. J Virol 83: 8409-8417.
53. Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, et al. (2008) Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol 82: 2313-2323.
54. Hofmann H, Sindre H, Stamminger T, (2002) Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol 76: 5769-5783.
55. Netsawang J, Noisakran S, Puttikhunt C, Kasinrerk W, Wongwiwat W, et al. (2010) Nuclear localization of dengue virus capsid protein is required for DAXX interaction and apoptosis. Virus Res 147: 275-283.
56. Gurer C, Berthoux L, Luban J, (2005) Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol 79: 910-917.
57. Li XD, Makela TP, Guo D, Soliymani R, Koistinen V, et al. (2002) Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. J Gen Virol 83: 759-766.
58. Woodhall DL, Groves IJ, Reeves MB, Wilkinson G, Sinclair JH, (2006) Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281: 37652-37660.
59. Baldick CJ Jr, Marchini A, Patterson CE, Shenk T, (1997) Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J Virol 71: 4400-4408.
60. Nicholson IP, Sutherland JS, Chaudry TN, Blewett EL, Barry PA, et al. (2009) Properties of virion transactivator proteins encoded by primate cytomegaloviruses. Virol J 6: 65.
61. Jung YS, Kim HY, Lee YJ, Kim E, (2007) Subcellular localization of Daxx determines its opposing functions in ischemic cell death. FEBS Lett 581: 843-852.
62. Bieniasz PD, (2006) Late budding domains and host proteins in enveloped virus release. Virology 344: 55-63.
63. Watcharananan SP, Kiertiburanakul S, Piyatuctsanawong W, Anurathapan U, Sungkanuparph S, et al. (2010) Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome. Pediatr Transplant 14: 675-681.
64. Sternsdorf T, Jensen K, Zuchner D, Will H, (1997) Cellular localization, expression, and structure of the nuclear dot protein 52. J Cell Biol 138: 435-448.
65. Kalejta RF, Shenk T, (2003) Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci U S A 100: 3263-3268.
66. Schreiner S, Wimmer P, Groitl P, Shuen-Yuan C, Blanchette P, et al. (2011) Adenovirus type 5 early region 1B 55 K oncoprotein dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells. J Virol 85: 8752-8765.
67. Groitl P, Dobner T, (2007) Construction of adenovirus type 5 early region 1 and 4 virus mutants. Methods Mol Med 130: 29-39.
68. Gunther T, Grundhoff A, (2010) The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6: e1000935.
69. Si H, Verma SC, Robertson ES, (2006) Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins. J Virol 80: 9017-9030.
70. Heim A, Ebnet C, Harste G, Pring-Akerblom P, (2003) Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 70: 228-239.
71. Dolken L, Ruzsics Z, Radle B, Friedel CC, Zimmer R, et al. (2008) High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. Rna 14: 1959-1972.
72. Ylosmaki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, et al. (2008) Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol 82: 11009-11015.
73. Catalucci D, Sporeno E, Cirillo A, Ciliberto G, Nicosia A, et al. (2005) An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors. J Virol 79: 6400-6409.
74. Shaw G, Morse S, Ararat M, Graham FL, (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb J 16: 869-871.
75. Kindsmuller K, Schreiner S, Leinenkugel F, Groitl P, Kremmer E, et al. (2009) A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication. J Virol 83: 9045-9056.